Association between AXL, Hippo Transducers, and Survival Outcomes in Male Breast Cancer

The Genomic Landscape of Male Breast Cancers

(2016) Salvatore Piscuoglio et al.   CLINICAL CANCER RESEARCH

Hippo pathway and protection of genome stability in response to DNA damage

(2016) Dafni E. Pefani et al.   FEBS Journal

Topographic expression of the Hippo transducers TAZ and YAP in triple-negative breast cancer treated with neoadjuvant chemotherapy

(2016) Patrizia Vici et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

HMG-CoAR expression in male breast cancer: relationship with hormone receptors, Hippo transducers and survival outcomes

(2016) Anna Di Benedetto et al.   Scientific Reports

Obesity and male breast cancer: provocative parallels?

(2015) Matthew P. Humphries et al.   BMC Medicine

YAP enhances the pro‐proliferative transcriptional activity of mutant p53 proteins

(2015) Silvia Di Agostino et al.   EMBO REPORTS

The Hippo transducers TAZ and YAP in breast cancer: oncogenic activities and clinical implications

(2015) Marcello Maugeri-Saccà et al.   EXPERT REVIEWS IN MOLECULAR MEDICINE

Down-regulation of LATS kinases alters p53 to promote cell migration

(2015) Noa Furth et al.   GENES & DEVELOPMENT

A laminin 511 matrix is regulated by TAZ and functions as the ligand for the α6Bβ1 integrin to sustain breast cancer stem cells

(2015) Cheng Chang et al.   GENES & DEVELOPMENT

Role of gonadotropin-releasing hormone analogues in metastatic male breast cancer: results from a pooled analysis

(2015) Luigi Di Lauro et al.   Journal of Hematology & Oncology

Genome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growth

(2015) Francesca Zanconato et al.   NATURE CELL BIOLOGY

MicroRNA-125a influences breast cancer stem cells by targeting leukemia inhibitory factor receptor which regulates the hippo signaling pathway

(2015) Sushmita Bose Nandy et al.   Oncotarget

The Hippo transducer TAZ as a biomarker of pathological complete response in HER2-positive breast cancer patients treated with trastuzumab-based neoadjuvant therapy

(2015) Patrizia Vici et al.   Oncotarget

Molecular profiling and computational network analysis of TAZ-mediated mammary tumorigenesis identifies actionable therapeutic targets

(2015) Costa Frangou et al.   Oncotarget

AXL kinase as a novel target for cancer therapy

(2015) Xiaoliang Wu et al.   Oncotarget

Hypoxia-inducible factor 1 mediates TAZ expression and nuclear localization to induce the breast cancer stem cell phenotype

(2015) Lisha Xiang et al.   Oncotarget

Antiandrogen therapy in metastatic male breast cancer: results from an updated analysis in an expanded case series

(2014) Luigi Di Lauro et al.   BREAST CANCER RESEARCH AND TREATMENT

Mutant Gq/11 Promote Uveal Melanoma Tumorigenesis by Activating YAP

(2014) Fa-Xing Yu et al.   CANCER CELL

YAP/TAZ Incorporation in the β-Catenin Destruction Complex Orchestrates the Wnt Response

(2014) Luca Azzolin et al.   CELL

Cytokinesis Failure Triggers Hippo Tumor Suppressor Pathway Activation

(2014) Neil J. Ganem et al.   CELL

Metabolic control of YAP and TAZ by the mevalonate pathway

(2014) Giovanni Sorrentino et al.   NATURE CELL BIOLOGY

TAZ is required for metastatic activity and chemoresistance of breast cancer stem cells

(2014) M Bartucci et al.   ONCOGENE

The Biology of YAP/TAZ: Hippo Signaling and Beyond

(2014) Stefano Piccolo et al.   PHYSIOLOGICAL REVIEWS

Energy Stress Regulates Hippo-YAP Signaling Involving AMPK-Mediated Regulation of Angiomotin-like 1 Protein

(2014) Michael DeRan et al.   Cell Reports

Male breast cancer: risk factors, biology, diagnosis, treatment, and survivorship

(2013) K. J. Ruddy et al.   ANNALS OF ONCOLOGY

Letrozole combined with gonadotropin-releasing hormone analog for metastatic male breast cancer

(2013) Luigi Di Lauro et al.   BREAST CANCER RESEARCH AND TREATMENT

Aromatase inhibitors with or without gonadotropin-releasing hormone analogue in metastatic male breast cancer: a case series

(2013) F Zagouri et al.   BRITISH JOURNAL OF CANCER

The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment

(2013) Randy Johnson et al.   NATURE REVIEWS DRUG DISCOVERY

The Landscape of Candidate Driver Genes Differs between Male and Female Breast Cancer

(2013) Ida Johansson et al.   PLoS One

Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility

(2013) Z. Wang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Fulvestrant and male breast cancer: a case series

(2012) F. Zagouri et al.   ANNALS OF ONCOLOGY

Oncogene amplification in male breast cancer: analysis by multiplex ligation-dependent probe amplification

(2012) Robert Kornegoor et al.   BREAST CANCER RESEARCH AND TREATMENT

Adjuvant therapy with tamoxifen compared to aromatase inhibitors for 257 male breast cancer patients

(2012) Holm Eggemann et al.   BREAST CANCER RESEARCH AND TREATMENT

β-Catenin-Driven Cancers Require a YAP1 Transcriptional Complex for Survival and Tumorigenesis

(2012) Joseph Rosenbluh et al.   CELL

Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP

(2012) Y. Liu-Chittenden et al.   GENES & DEVELOPMENT

A comparative biomarker study of 514 matched cases of male and female breast cancer reveals gender-specific biological differences

(2011) Abeer M. Shaaban et al.   BREAST CANCER RESEARCH AND TREATMENT

The Hippo Transducer TAZ Confers Cancer Stem Cell-Related Traits on Breast Cancer Cells

(2011) Michelangelo Cordenonsi et al.   CELL

A cell-based assay to screen stimulators of the Hippo pathway reveals the inhibitory effect of dobutamine on the YAP-dependent gene transcription

(2011) Y. Bao et al.   JOURNAL OF BIOCHEMISTRY

Gene expression analysis reveals a different transcriptomic landscape in female and male breast cancer

(2010) Maurizio Callari et al.   BREAST CANCER RESEARCH AND TREATMENT

High-resolution genomic profiling of male breast cancer reveals differences hidden behind the similarities with female breast cancer

(2010) Ida Johansson et al.   BREAST CANCER RESEARCH AND TREATMENT

Aromatase inhibition in male breast cancer patients: biological and clinical implications

(2009) J. Doyen et al.   ANNALS OF ONCOLOGY

Male Breast Cancer: A Population-Based Comparison With Female Breast Cancer

(2009) William F. Anderson et al.   JOURNAL OF CLINICAL ONCOLOGY